-
The established causal relationship between endothelial dysfunction and erectile dysfunction (ED) provides mechanistic insight into an obesity-sexual health linkage.
-
A short-acting dihydropyridine calcium channel blocker with a rapid onset of action has been approved for intravenous use to reduce blood pressure.
-
A randomized controlled trial of newly diagnosed type 2 diabetic patients not on insulin showed an increased depression score in those performing home glucose monitoring and no improvement in glycemic control.
-
A very large prospective study found no evidence that nuts, corn, popcorn, or seeds increased diverticular disease or its complications.
-
Whereas its potential benefits remain uncertain, prostate-specific antigen (PSA) screening may be associated with psychological harms. There has been a recent update to the screening guidelines by the U.S. Preventive Services Task Force (USPSTF).
-
Women who do not take supplemental calcium frequently need more education, and state they would be positively influenced by their physician's recommendations.
-
Over a 5-year period, 16% of elderly people developed mild cognitive impairment (MCI) and had double the risk of developing Alzheimer's disease (AD) than normals; however, 30% with MCI reverted to normal.
-
After skin cancer, prostate cancer (P-CA) is the most common cancer among American men. Despite the absence of major consensus group endorsement, androgen deprivation therapy (ADT) has been sufficiently popular that in a 2003 report, ADT was employed second only to surgery for localized disease.
-
The combination of the first direct renin inhibitor and hydrochlorothiazide was approved by the FDA this year for the treatment of hypertension.
-
Women who had sexual dysfunction that was believed to be a side effect of antidepressants were more likely to report improved sexual function if they were assigned to the sildenafil, rather than to the placebo arm of a placebo-controlled trial.